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1991-7902/Copyrightª 2015, AssociatioAbstract Background/purpose: Evidence shows that there is a relationship between hypoxia
and inflammatory response in periodontitis. Hypoxia-inducible factor (HIF)-1a is a major regu-
lator of energy homeostasis and cellular adaptation to low oxygen stress. Although experi-
mental results demonstrate an association between HIF-1a and vascular endothelial growth
factor (VEGF)-C in tumor angiogenesis, the role of HIF-1a and VEGF-C in the pathogenesis of
periodontitis is still ambiguous. So far, limited attention has been given to the role of hypoxia
and VEGF-C in periodontitis. The present study aimed to investigate the expression and distri-
bution of HIF-1a and VEGF-C in gingival tissue samples from patients with different stages of
chronic periodontitis and healthy individuals.
Materials and methods: A total of 56 samples were involved in this study, including moderate
chronic periodontitis (n Z 20), advanced chronic periodontitis (n Z 20), and healthy control
tissues (nZ 16). The gingival specimens were stained with hematoxylin and eosin for histopa-
thology. The expression of HIF-1a and VEGF-C in gingival tissues was detected by immunohis-
tochemical staining.
Results: HIF-1a and VEGF-C were found in gingival tissues from patients with different stages
of chronic periodontitis as well as healthy control tissues. HIF-1a protein was expressed mainly
in the epithelial layer of gingival tissues, and VEGF-C protein was mostly located in the connec-
tive tissue papilla of gingival tissues. Compared with healthy controls, the expression of HIF-1a
and VEGF-C in chronic periodontitis groups was significantly higher (P < 0.01), and the density
of HIF-1a and VEGF-C in advanced chronic periodontitis group was even significantly higher
than that in the moderate chronic periodontitis group (P < 0.01).tomatology, College of Medicine, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632,
63.com (Q.-Y. Shi).
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324 Q.-Y. Shi et alConclusion: Our results suggest that the expression of HIF-1a and VEGF-C increased with
severity of periodontitis. So, we conclude that HIF-1a may play an important role in the path-
ophysiology of human periodontitis and may be related to the function of VEGF-C during peri-
odontitis.
Copyright ª 2015, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.Introduction
Periodontitis is a common chronic infectious disease char-
acterized by the destruction of tooth-supporting tissue,
finally leading to tooth loss.1 In periodontitis, both oxygen
supply and demand in the periodontium may be signifi-
cantly shifted, leading to inflammation-associated tissue
hypoxia and metabolic acidosis, disturbing microcirculation
and increasing leukocyte infiltration, particularly myeloid
cells such as polymorphonuclear leukocytes (PMNs) and
monocytes.2 Low-oxygen tolerance is supported by an
adaptive response that includes a coordinate shift in
metabolism and the activation of a transcriptional program
that is driven by the hypoxia-inducible factor (HIF)
pathway.3 A few affected pathways generally characterize
HIF-mediated adaptation responses, including upregulation
of angiogenic, erythropoietic, and glycolytic transcripts.4
Experiments have shown that hypoxia appears to stimu-
late both innate and adaptive immune responses.5 Results
by Motohira et al6 showed that hypoxia could stimulate the
periodontal ligament cells to produce vascular endothelial
growth factor (VEGF), interleukin (IL)-6, and prostaglandin
(PG)E2, which could result in the resorption of alveolar
bone in periodontitis.
HIF-1a is a transcription regulatory factor that is enco-
ded by activated gene when organization is under hypoxic.7
HIF-1a is a major regulator of energy homeostasis and
cellular adaptation to low-oxygen stress.8 HIF-1 functions
as a master regulator of cellular and systemic homeostatic
response to hypoxia by activating the transcription of many
genes, including those involved in energy metabolism,
angiogenesis, and apoptosis, and other genes whose protein
products increase oxygen delivery or facilitate metabolic
adaptation to hypoxia.9 HIF-1 thus plays an essential role in
embryonic vascularization, tumor angiogenesis, and path-
ophysiology of ischemic disease.10 At the molecular level,
HIF-1a binds to hypoxia response elements (HREs) in the
promoters of target genes, such as VEGF and erythropoi-
etin, and promotes their expression.11 Hypoxia through
activation of HIF-dependent transcription of proangiogenic
factors such as VEGF is a major mechanism behind tumor
angiogenesis. Experiments showed that hypoxia-induced
VEGF expression in both neuroblastoma and breast cancer
cell lines is primarily driven by HIF-2a at prolonged hypoxia,
whereas HIF-1a is the major VEGF inducer during acute
hypoxic conditions.12 So far, knowledge is limited in the
role of expression of HIF-1a and VEGF in the pathogenesis
of periodontitis.
VEGF produced by many normal and tumor cells plays a
key role in regulating normal and abnormal angiogenesis.VEGF is an important growth factor proven to be specific
and critical for a mitogen for vascular endothelial cells
derived from arteries, veins, and lymphatics, but it is
devoid of consistent and appreciable mitogenic activity for
other cell types.13 It binds to endothelial cell surface re-
ceptors and activates various functions of the cell including
angiogenesis.14 The periodontal vasculature is affected
profoundly during the progression of periodontitis.15 VEGF
primarily stimulates endothelial cell proliferation, chemo-
taxis, migration, and survival, as well as increasing micro-
vascular permeability and the secretion of proteolytic
enzymes.16,17 VEGF-C increases vascular permeability,
which can contribute to the formation of inflammation in
the early stages of periodontal disease. VEGF-C seems to be
crucial for lymphangiogenesis during periodontal disease
development, and upregulation of VEGF-C in recruited im-
mune cells is likely important for the growth of lymphatic
vessels.18 The role of VEGF-C in the pathogenesis of peri-
odontitis is still ambiguous. Although Mkonyi et al19 have
already observed that increased numbers of immune cells
expressed VEGF-C in the gingiva after infection, along with
upregulation of IL-1b and tumor necrosis factor (TNF)-a at
protein levels. On the contrary, Ozcelik et al20 demon-
strated that the expression of VEGF-A and VEGF-C was
significantly lower in patients with scleroderma, when
compared with the controls. Although higher levels of in-
flammatory infiltrate and microvessel density were found in
the gingival biopsy samples.20
Oxygen metabolism has a critical role in maintaining the
normal physiological functions of periodontal tissues.21
During the progression of periodontitis, the status of
ischemia and hypoxia in tissue induced the expression of
HIF-1a, which can accelerate the expression of VEGF-C.
Moreover, VEGF-C is a receptor activator of nuclear factor
kB ligand (RANKL) target gene in osteoclasts, and functions
as an autocrine factor regulating osteoclast activity. Thus,
VEGF-C plays a prominent role in the process of enhancing
the resorptive activity of osteoclasts.22 Therefore, the
present study aimed to investigate the expression and dis-
tribution of HIF-1a and VEGF-C in human gingival tissues at
different stages of chronic periodontitis.Materials and methods
Gingival tissue collection
The gingival biopsies were obtained from the patients
attending the Department of Periodontology, Liwan Sto-
matological Teaching Hospital of Jinan University,
Table 1 Demographic and pathological data of chronic periodontitis patients and control individuals.
Groups Total (n) Sex (male/female)
n (%)
Age (y) PD (mm) GI
Range Median
Normal control 16 8/8 (50/50) 25e45 34 d 0.3
Moderate periodontitis 20 8/12 (40/60) 36e63 51 5.4 2.6
Advanced periodontitis 20 11/9 (55/45) 32e65 49 6.3 3.5
GI Z gingival index; PD Z pocket depth.
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2013. Fifty-six gingival tissue specimens were obtained
from 20 patients with chronic moderate periodontitis, 20
patients with chronic advanced periodontitis, and 16 clini-
cally periodontal healthy individuals. The inclusion criteria
were: (1) good health without systemic diseases; (2) no
medication was taken at least 2 months ago; (3) no peri-
odontal therapy within 1 year; and (4) pregnant or lactating
women were excluded, and postmenopausal women or
others under estrogen therapy were excluded. The clini-
cally healthy specimens were harvested from teeth
extracted for orthodontic reasons, generally premolars.
Specimens of moderate periodontitis were obtained from
patients undergoing periodontal surgery, and the specimens
of advanced periodontitis were obtained from loose tooth
extractions that had severe clinical attachment loss and
alveolar bone destruction. All individuals in the moderate
and advanced periodontitis groups had previous oral hy-
giene instruction, scaling, and root planning prior to sur-
gery, but continued to have bleeding on probing from the
base of the pocket. Periodontitis were diagnosed according
to the 1999 American Academy of Periodontology classifi-
cation, by measuring gingival index (GI), bleeding on
probing (BOP), probing pocket depth (PD), clinical attach-
ment loss (CAL), and by radiography examination.23 The
clinically healthy specimen sites met the following criteria:
probing depth not exceeding 3 mm; absence of BOP; GIZ 0
or 1; and no radiographic evidence of alveolar bone loss.
Patients with moderate periodontitis had gingival inflam-
mation (GI Z 2 or 3), BOP, PD, or AL of 4e6 mm and
alveolar bone loss of 4e6 mm. Patients diagnosed with
advanced periodontitis presented with the following sig-
nals: GIZ 3 or 4; PD or AL > 6 mm; tooth mobility of Class II
or III; alveolar bone loss 6 mm. They were 25e65 years
old, and 27 patients were male (mean age Z 43 years,
standard deviation Z 11.6) and 29 patients were female
(mean age Z 42 years, standard deviation Z 13.8). The
informed consent from the patients obtained prior to the
study was approved by the Ethics in Clinical Research
Committee of Jinan University. The demographic and
pathological data of the patients and healthy individuals
included in this study are shown in Table 1. There was no
significant difference in age or sex among the three
experiment groups.Histological staining and grading
The collected specimens were fixed in 10% neutral-buffered
formaldehyde solution for a minimum of 48 hours before
being embedded in paraffin. The 5-mm thick paraffin slideswere dewaxed in xylene and rehydrated through a series of
graded ethanol, and stained using standard methods with
hematoxylin and eosin, and then evaluated for inflamma-
tory changes. The semiquantitative grade of inflammation
in gingival tissues was described on a scale from 0 to 3:
0 Z no inflammation, no inflammatory cell infiltration;
1 Z mild inflammation, local focal inflammatory cells
infiltration; 2 Z moderate inflammation, spotty and flaky
inflammatory cells infiltration; and 3 Z severe inflamma-
tion, diffuse inflammatory cells infiltration. The grade of
inflammation of 10 specimens was measured blindly by two
pathologists and the average grade of inflammation was
calculated. The sections were visualized and photographed
by a Leica DM2500B microscope (Leica Microsystems, Wet-
zlar, Germany).Immunohistochemistry
Serial paraffin sections (5 mm thick) were treated with
conventional dewaxing and hydration. For antigen
retrieval, the slides placed in 0.01M citrate buffer solution
(pH Z 6.0; ZhongShan Goldenbridge Biotechnology, Bei-
jing, China) were heated with high fire for 10 minutes to
boil, and with moderate fire for 10 minutes to maintenance
in a microwave. Endogenous peroxidase activity was
blocked with 3% hydrogen peroxide. The slides were
treated with blocking serum (ZLI-9022; ZhongShan Gold-
enbridge Biotechnology) for 30 minutes at room tempera-
ture. The primary antibodies used in this study were anti-
HIF-1a antibody (1:150 dilution; 400080; Millipore Biotech-
nology, Billerica, Massachusetts, USA) and anti-vegf-C
antibody (1:100 dilution; ZA-0266; ZhongShan Golden-
bridge Biotechnology). All antibodies were diluted in anti-
body diluent (ZLI-9028; ZhongShan Goldenbridge
Biotechnology). After incubating with blocking serum for 30
minutes, the sections were incubated with primary anti-
bodies overnight at 4C. The sections were subsequently
incubated with goat anti-rabbit immunoglobulin G anti-
bodyehorseradish peroxidase multimers (PV-6001; Zhong-
Shan Goldenbridge Biotechnology) for 30 minutes at room
temperature, followed by a further coloration with 3,30-
diaminobenzidine (DAB) reagent (ZLI-9017; ZhongShan
Goldenbridge Biotechnology) for 8 minutes. Each step was
followed by three washes with phosphate-buffered saline
for 5 minutes each time. Finally, the sections were coun-
terstained with Mayer’s hematoxylin and examined under a
light microscope. Negative control staining with no primary
antibody was performed by replacing the primary antibody
with phosphate-buffered saline, and the other steps were
the same as periodontitis groups. Immunohistochemical
326 Q.-Y. Shi et alstaining was evaluated in visual fields at a magnification of
200 under a light microscope.
Assessment of immunohistochemical staining
The slides were analyzed under light microscopy by two
pathologists who did not know the clinical diagnosis. The
immunohistochemical positive signal was the tiny brown
particles that were located in nucleus or cytoplasm. The
number of total positive stained cells in gingival tissues was
counted in high-power microscopic fields (200) of each
specimen. The size of gingival tissues in each slice was
recorded. The density of HIF-1a and VEGF-C positive cells
was calculated (number/mm2). HIF-1a positive cell density
(number/mm2) Z total numbers of HIF-1a positive cells of
each slice/the tissue size of each slice (mm2); VEGF-C
positive cell density (number/mm2) Z total numbers ofFigure 1 Representative photomicrographs of human periodont
slight inflammatory infiltrate in clinically healthy gingival tissues. (C
group. (E, F) Intense inflammatory infiltrate in advanced periodonti
400.VEGF-C positive cells of each slice/the tissue size of each
slice (mm2).Statistical analysis
All of the periodontal measurements were done in a blind
fashion on coded specimens, and the quantitative mea-
surements were made twice. All statistical analyses were
performed using SPSS version 13.0 (SPSS Inc., Chicago, IL,
USA). Nonparametric tests were chosen for variables since
the data were not distributed normally. Differences in
periodontal histopathological inflammation score and the
density of HIF-1a, VEGF-C of different groups were
analyzed using the KruskaleWallis H test. Two-group com-
parisons were assessed using Nemenyi test. The relation-
ship between the expression level of HIF-1a and VEGF-C inal histology stained with hematoxylin and eosin. (A, B) No or
, D) Moderate inflammatory infiltrate in moderate periodontitis
tis group. Original magnification: A, C, and E, 200; B, D, and F,
HIF-1a and VEGF-C in human chronic periodontitis 327gingival tissues was analyzed with Pearson correlation. A P
value <0.05 was considered statistically significant.
Results
Histological analysis
Histologically, no inflammatory infiltrate was found in
clinically healthy gingival tissues (Figure 1A and 1B).
Compared with healthy controls, the specimens of moder-
ate periodontitis showed moderate inflammatory infiltra-
tion (Figure 1C and 1D), while advanced periodontitis group
presented intense inflammatory cell infiltration (Figure 1E
and 1F). The inflammatory scores of each group are shown
in Figure 2. Compared with healthy controls, the inflam-
matory scores of periodontal tissues from both moderate
and advanced periodontitis groups were significantly higher
(P < 0.01). In addition, the inflammatory score of peri-
odontal tissues from the advanced periodontitis group was
significantly higher than that of the moderate periodontitis
group (P < 0.01).
Expression of HIF-1a protein in human gingival
tissues
The HIF-1a-positive cells exhibited brown particles in the
nucleus or cytoplasm, mainly localized in the epithelial
layer of gingival tissues (Figure 3). The density of HIF-1a-
positive cells of each group is shown in Figure 4. Compared
with healthy controls, the density of HIF-1a-positive cells
significantly increased in the periodontitis groups
(P < 0.01), and the density of HIF-1a-positive cells in theFigure 2 Inflammatory score in the specimen (mean  SD).
(A) Healthy control group (nZ 16). (B) Moderate periodontitis
group (n Z 20). (C) Advanced periodontitis group (n Z 20).
* P < 0.01, compared to healthy control; ** P < 0.01, compared
to moderate periodontitis. 0 Z no inflammation, no inflam-
matory cell infiltration; 1 Z mild inflammation, local focal
inflammatory cells infiltration; 2 Z moderate inflammation,
spotty and flaky inflammatory cells infiltration; 3 Z severe
inflammation, diffuse inflammatory cells infiltration;
SD Z standard deviation.advanced chronic periodontitis group was significantly
higher than that of the moderate chronic periodontitis
group (P < 0.01).
The distribution of HIF-1a-positive cells in human gingival
tissues was also evaluated and calculated. The results
showed that 96.34  1.80% of HIF-1a-positive cells was
located in the epithelial layer of gingival tissues, whereas
3.67  1.80% of HIF-1a-positive cells was located in the
connective tissue papilla of gingival tissues. The different
ratio of HIF-1a-positive cells in epithelial cell layers and in
connective tissues of each group is shown in Figure 5.
Expression of VEGF-C protein in human gingival
tissues
The VEGF-C-positive cells revealed brown particles in the
nucleus or cytoplasm, mainly localized in the connective
tissue papilla of gingival tissues (Figure 6). The density of
VEGF-C-positive cells of each group is shown in Figure 7.
Only a few weakly VEGF-C-positive cells were observed in
the healthy control group. Compared with the healthy
controls, the density of VEGF-C-positive cells was signifi-
cantly higher in the chronic periodontitis groups (P < 0.01),
and the density of VEGF-C-positive cells in the advanced
chronic periodontitis group was significantly higher than
that of the moderate chronic periodontitis group (P < 0.01).
The distribution of VEGF-C-positive cells in human
gingival tissues was also evaluated and calculated. The
results showed that 7.95  5.32% of VEGF-C-positive cells
was located in the epithelial layer of gingival tissues,
whereas 92.03  5.30% of VEGF-C-positive cells was located
in the connective tissues of gingival tissues. The different
ratio of VEGF-C-positive cells in epithelial cell layers and in
connective tissues of each group is shown in Figure 8.
Negative controls
No cells positive for hypoxia-inducible factor-1a or vascular
endothelial growth factor-C were found in negative con-
trols (Figure 9).
Correlation analysis between expression levels of
HIF-1a and VEGF-C
Pearson correlation analysis showed that there was a pos-
itive correlation between the expression level of HIF-1a and
VEGF-C in gingival tissues of healthy controls (r Z 0.963,
P Z 0.000), moderate periodontitis group (r Z 0.972,
PZ 0.000) and advanced periodontitis group (r Z 0.987,
P Z 0.000) (Figure 10).
Discussion
The most common reason for tooth loss is periodontal dis-
ease. Until now, the underlying mechanisms involved in
periodontal disease have not been fully elucidated. As
hypoxia is a common feature of inflamed microenviron-
ments, the moderation of hypoxia may be a significant
contributory mechanism in periodontitis.24 The microenvi-
ronment of inflamed and injured tissue in the periodontium
Figure 3 Immunostaining for HIF-1a protein in human gingival tissues. Positively stained cells can be visualized by the brown
particles in nucleus or cytoplasm, mostly located in the epithelial layer. There were a few weak positive cells expressing HIF-1a
protein observed in the healthy control group (A and B). In the moderate chronic periodontitis group (C and D), the number of HIF-
1a-positive cells significantly increased. Numerous cells with strong nuclear or cytoplasmic staining were observed in the advanced
chronic periodontitis group (E and F). Original magnification: A, C, and E, 200; B, D and F, 400. HIFZ hypoxia-inducible factor.
328 Q.-Y. Shi et alis characterized by low levels of oxygen and glucose, and
high levels of inflammatory cytokines, reactive oxygen, and
nitrogen species and metabolites. Responses to hypoxia are
mediated by HIF protein, a transcription factor that induces
genes whose products restore blood supply, nutrients, and
energy production to maintain tissue homeostasis.25 To the
best of our knowledge, it is not known whether HIF-1a
protein is expressed in gingival tissues of healthy individuals
and periodontitis patients. Our results showed that strong
expression of HIF-1a was observed in the epithelial layer of
gingival tissues in chronic periodontitis, and the increased
expression of HIF-1a was related to the enhanced severity
of periodontitis; thus, our findings indicated that peri-
odontitis is under anoxic conditions. Hypoxia is a vital
element in the pathogenesis of periodontal disease; a
previous study showed that there is a correlation of peri-
odontitis severity with psychological stress and periodontal
tissue hypoxia.26HIF-1 consists of a constitutively expressed HIF-1b sub-
unit and an oxygen-regulated HIF-1a subunit. Under normal
oxygen tension, HIF-1a is rapidly degraded by the ubiq-
uitineproteasome pathway, however, under hypoxic con-
ditions, HIF-1a is stabilized by the attenuation of proly1
hydroxylase activity.27 The accumulated HIF-1a hetero-
dimerizes with HIF-1b and translocates into the nucleus.
The HIF-1 complex binds to the HRE, composed of a core 50-
ACGTG-30 sequence, in concert with the transcriptional
coactivator p300/CREB-binding protein (CBP),28 thereby
activating the expression of target genes, such as VEGF and
erythropoietin.29 HIF-1a is a major regulator of energy ho-
meostasis and cellular adaptation to low-oxygen stress.
Recently, HIF-1a has been discovered to function as a
global regulator of macrophage, neutrophil inflammatory,
and innate immune functions, as befits these specialized
phagocytic cells that operate effectively in the hypoxic
microenvironments of infected tissues.30 In cells of the
Figure 4 Density of hypoxia-inducible factor-1a positive
cells (mean  standard deviation). (A) Healthy control group
(n Z 16). (B) Moderate periodontitis group (n Z 20). (C)
Advanced periodontitis group (n Z 20). * P < 0.01, compared
to healthy control; ** P < 0.01, compared to moderate
periodontitis.
Figure 5 Different ratio of HIF-1a-positive cells in epithelial
cell layers and in connective tissues of each group
(mean  standard deviation). The HIF-1a-positive cells were
mainly localized in the epithelial layer of gingival tissues. (A)
Healthy control group (n Z 16). (B) moderate periodontitis
group (n Z 20). (C) Advanced periodontitis group (n Z 20).
HIF Z hypoxia-inducible factor.
HIF-1a and VEGF-C in human chronic periodontitis 329innate and adaptive immune system, HIF-1 is upregulated
by bacterial and viral compounds, even under normoxic
conditions. This upregulation prepares these cells to
migrate, and to function in hypoxic and inflamed tissues.
Therefore, HIF-1a protein as a hypoxic marker was chosen
to evaluate the hypoxic degree in gingival tissues with
periodontitis by immunohistochemistry in this study. To the
best of our knowledge, little is known about whether HIF-1
is a potentially important marker for human chronic peri-
odontitis. Ng et al31 indicated that HIF-1a is expressed in
healthy and diseased periodontium. Our results showedsimilar findings in human gingival tissues with periodontitis.
Compared with the healthy controls, immunohistochem-
istry indicated increased expression level of HIF-1a protein
in chronic periodontitis. We also observed that expression
of HIF-1a and inflammatory score in advanced periodontitis
were significantly higher than those of moderate peri-
odontitis. In particular, increased expression of HIF-1a
protein in fibroblast-like cells and infiltrating inflammatory
cells in gingival biopsies from patients with chronic peri-
odontitis indicates that the HIF-1 pathway is involved in
controlling periodontal inflammatory responses. The
increased expression of HIF-la in some gingival epithelial
cells suggests that a steep oxygen gradient may exist be-
tween the gingival epithelium and dermal vessels,
depending on the diffusion distance, local metabolism, and
oxygenated blood supply.31 Once extravasated from the
vasculature, the activity of cells is further enhanced by
stimulation of HIF-1 induced by proinflammatory cytokines
like IL-1b, TNF-a, and locally expressed tissue factors.32
Yoshida et al33 demonstrated that HIF signaling is regu-
lated at post-translational levels via interactions with the
master regulator of inflammation NF-kB. NF-kB is a regu-
lator of innate immunity and inflammatory signaling.33 The
RANKL and osteoprotegerin pathway regulates osteoclast
differentiation and function during normal physiological
bone remodeling, and RANK, RANKL, and osteoprotegerin
proteins may play a major role in the bone loss occurring in
periodontitis, which are differentially expressed in peri-
odontal tissue.34
VEGF-C belongs to a family of heparin-binding growth
factors that include VEGF-B, VEGF-C, VEGF-D, and
placental-like growth factor.35 VEGF is a well-known
angiogenic factor that is important for vascular develop-
ment and maintenance in all mammalian organs. The
development of molecular tools and pharmacological
agents to selectively inhibit VEGF function and block
angiogenesis and/or vascular permeability has led to great
promise in the treatment of various cancers, macular
degeneration, and wound healing.35 However, VEGF is also
important in animals for the regulation of angiogenesis,
stem cell and monocyte/macrophage recruitment, main-
tenance of kidney and lung barrier functions, and neuro-
protection.35 In addition to its role in regulating endothelial
cell proliferation, migration, and cell survival, VEGF re-
ceptors are also located on many nonendothelial cells and
act through autocrine pathways to regulate cell survival
and function. VEGF expression is regulated by a variety of
stimuli such as nitric oxide, growth factors, and HIF-1a.36,37
In allergic airway disease, the accumulated data indicated
that the tight regulation of HIF-1a activity and VEGF
expression is performed by the phosphoinositide 3-kinase/
serine threonine kinase/mammalian target of rapamycin
(PI3K/Akt/mTOR) signaling cascade.36 HIF-1 is a key tran-
scription factor in hypoxia-mediated VEGF gene upregula-
tion.37 VEGF protein binds to its receptor, and these
compounds mediate physiological functions. It is well
established that the expression of VEGF is upregulated by
hypoxia, and the expression of VEGF in response to hypoxia
depends on transcriptional activation by a heterodimer
comprising HIF-1a and aryl hydrocarbon receptor nuclear
translocator (ARNT)1.38 HIF-1a binds to HRE of target genes
such as VEGF, erythropoietin, and glycolytic enzymes.39
Figure 6 Immunostaining for VEGF-C protein in human gingival tissues. The VEGF-C-positive cells were mainly localized in
connective tissue papilla of gingival tissues. There were a few cells weakly positive for VEGF-C protein in the healthy control group
(A and B). The number of VEGF-C-positive cells significantly increased in the moderate chronic periodontitis group (C and D).
Numerous cells with strong nuclear or cytoplasmic staining were observed in the advanced chronic periodontitis group (E and F).
Original magnification: A, C, and E, 200; B, D, and F, 400. VEGF Z vascular endothelial growth factor.
Figure 7 Density of cells positive for vascular endothelial
growth factor-C. (A) Healthy control group (n Z 16). (B)
Moderate periodontitis group (n Z 20). (C) Advanced peri-
odontitis group (n Z 20). * P < 0.01, compared to healthy
control; ** P < 0.01, compared to moderate periodontitis.
Figure 8 Different ratio of cells positive for vascular endo-
thelial growth factor-C in epithelial cell layers and in connec-
tive tissues of each group (mean  standard deviation). (A)
Healthy control group (n Z 16). (B) Moderate periodontitis
group (n Z 20). (C) Advanced periodontitis group (n Z 20).
Figure 9 No cells positive for hypoxia-inducible factor/vascular endothelial growth factor-C positive cell were found in
negative controls. (A, B) Healthy control group. (C, D) Moderate periodontitis group. (E, F) Advanced periodontitis group. Original
magnification: A, C, and E, 200; B, D, and F, 400.
HIF-1a and VEGF-C in human chronic periodontitis 331The binding of HIF-1a to the HRE in the VEGF promoter is a
predominant inducer of VEGF expression.38 The role of
VEGF-C in inflammation is not fully understood. In chronic
airway inflammation induced by Mycoplasma pulmonis
infection or in chronic arthritis induced by the over-
expression of TNF,40 systemic inhibition of the VEGF re-
ceptor 3 signaling pathway caused exaggerated tissue
ischemia, edema, and damage. However, there is no report
that VEGF-C has immunomodulatory effects on periodon-
titis. In the present study, our results showed that VEGF-C
was weakly expressed in healthy tissues, and there was
significantly higher expression in connective tissue papilla
of gingival tissues with chronic periodontitis; the expression
level in advanced chronic periodontitis was higher than that
of moderate chronic periodontitis. In our study, the distri-
bution of VEGF-C protein was marked in connective tissue
papilla of gingival tissues with chronic periodontitis, but
there was significantly reduced staining of VEGF-C protein
in the epithelial layer. The changes in the vascularity of theperiodontal connective tissues in advanced periodontitis
may be, in part, a consequence of altered expression of
angiogenic activity by the epithelium. In turn, this may
reflect the epithelial response to microbial flora in the
microenvironment of the periodontal pocket.41 The Pearson
correlation analysis showed a positive correlation between
the expression level of HIF-1a and VEGF-C in gingival tissues
with periodontitis. These results may be explained by the
fact that the signal of VEGF-C is upregulated by HIF-1a in
the pathogenesis of periodontitis. The expression of HIF-1a
correlates with hypoxia-induced angiogenesis as a result of
the induction of the major HIF-1 target gene VEGF.42 Many
studies have focused on the signaling pathway leading the
regulatory processes of the HIF-1 transcription factor.43 Our
findings suggested that VEGF-C protein expression may be
regulated by HIF-1a, involving the inflammation and regu-
lation of immune responses in the pathogenesis of peri-
odontitis. The expression level of HIF-1a and VEGF-C in
chronic periodontitis was higher than that in healthy
Figure 10 Correlation analysis between density of HIF-1a-
positive cells and VEGF-C-positive cells. (A) Healthy control
group (nZ 16). (B) Moderate periodontitis group (nZ 20). (C)
Advanced periodontitis group (n Z 20). Pearson correlation
analysis showed that there was a positive correlation between
expression level of HIF-1a and VEGF-C in gingival tissues in the
periodontitis groups and the healthy controls. There was a
strong correlation between expression of HIF-1a, VEGF-C, and
severity of human chronic periodontitis. HIF Z hypoxia-
inducible factor; VEGF Z vascular endothelial growth factor.
332 Q.-Y. Shi et alcontrols. Meanwhile, a higher expression level of HIF-1a
and VEGF-C were observed in advanced chronic periodon-
titis than that of moderate periodontitis. Similar results
were found in oral squamous cell carcinoma.44 Klatte et al45
demonstrated that the high expression of HIF-1a was
significantly associated with signals of the cell cycle,
apoptosis and expression of some crucial proteins such as
VEGF, platelet-derived growth factor, and epidermal
growth factor receptor. Under normoxic conditions, HIF-1a
expression is maintained at low steady-state levels by the
critical oxygen sensor prolyl hydroxylase 2. In chronic
periodontitis, HIF-1a is expressed highly in gingival fibro-
blasts and upregulates inflammatory factor transcription,
which promotes periodontal inflammation.46 In an in vitro
study investigating the effects of hypoxia on apoptosis and
autophagy of human periodontal ligament cells, it was
demonstrated that hypoxia induces apoptosis and auto-
phagic cell death in human periodontal ligament cells
through the HIF-1a pathway.47
Our results showed that the HIF-1a protein is mainly
expressed in the epithelial layer of gingival tissues, and
VEGF-C protein is mostly located in connective tissue
papilla of gingival tissues. Our study indicates that hypoxia
may play an important role in the pathogenesis of peri-
odontitis. Our first focus shows that there exists a strong
correlation between the expression of HIF-1a and VEGF-C
and severity of human chronic periodontitis. The results
suggest that HIF-1a may affect VEGF-C expression, thus
acting as a crucial regulator in the pathogenesis ofperiodontitis. This study highlights the potential of HIF-1a
as a therapeutic target against periodontitis.Conflicts of interest
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